GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
55,800
+600 (1.09%)
Aug 8, 2025, 3:30 PM KST
SolarWinds Revenue
GemVax&KAEL had revenue of 12.37B KRW in the quarter ending March 31, 2025, a decrease of -16.01%. This brings the company's revenue in the last twelve months to 60.33B, down -15.34% year-over-year. In the year 2024, GemVax&KAEL had annual revenue of 62.69B, down -13.18%.
Revenue (ttm)
60.33B
Revenue Growth
-15.34%
P/S Ratio
38.82
Revenue / Employee
314.24M
Employees
192
Market Cap
2,341.93B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 62.69B | -9.52B | -13.18% |
Dec 31, 2023 | 72.21B | -3.60B | -4.74% |
Dec 31, 2022 | 75.80B | 15.43B | 25.56% |
Dec 31, 2021 | 60.37B | -5.29B | -8.06% |
Dec 31, 2020 | 65.66B | 23.00B | 53.91% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
KB Financial Group | 15.69T |
Doosan Enerbility | 15.88T |